
    
      Patients that are currently receiving unmodified ECT at C.S.M Hospital will be eligible for
      the first phase of the study in which only data is collected. Three months after study start,
      patients who are to receive ECT for a psychiatric disorder will be eligible to participate in
      the intervention (introduction of propofol at a low dose prior to ECT). Data collection will
      include information such as demographics, ratings scales, seizure length, anxiety level,
      adverse events, and number of treatments.
    
  